Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
about
Consolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspectiveTreatment of peripheral T-cell lymphoma: are we data driven or driving the data?Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study.Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter studyOutcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphomaShould eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I studyPeripheral T-cell lymphoma: review and updates of current management strategiesAutologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis.The Outcome of HyperCVAD Combined with Alemtuzumab for the Treatment of Aggressive T-Cell and NK-Cell NeoplasmsPrimary treatment response rather than front line stem cell transplantation is crucial for long term outcome of peripheral T-cell lymphomas.Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma.Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease.New developments in the treatment of peripheral T-cell lymphoma - role of Belinostat.Safety and efficacy of pralatrexate in the management of relapsed or refractory peripheral T-cell lymphomaHow to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors.Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis.Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation.Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curve.Controversies in the treatment of lymphoma with autologous transplantation.Stem cell transplantation as a biological therapy for peripheral T-cell lymphomas.Transplantation for non-Hodgkin lymphoma.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).Treatment algorithms for mature T-cell and natural killer-cell neoplasms.Hematopoietic cell transplantation for lymphomas.Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for longPeripheral T-cell lymphomas: a review of current approaches and hopes for the future.Current state of art for transplantation paradigms in peripheral T-cell lymphomas.The potential of pralatrexate as a treatment of peripheral T-cell lymphoma.Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective.Autologous hematopoietic cell transplantation: an update for clinicians.Bone Marrow Transplantation for Peripheral T-Cell Non-Hodgkins' Lymphoma in First Remission.Investigational drugs for T-cell lymphoma.How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future.Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experienceImpact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas.Autologous stem cell transplantation for aggressive lymphomas.
P2860
Q26998446-D6B5587D-159E-42B1-BCAB-E12D2278B9F4Q30613674-EA0544DD-9E7C-4BB4-99DF-3A0B558FB0A2Q33396356-9770D3AF-3632-4084-B434-CFCFEC5678C2Q33434137-63B6FD42-E222-4E21-803B-8B8CBC07023DQ33608520-1AA1A8CF-EA32-4A19-886F-83C167E4B8D9Q33822764-BBA5C471-64FD-4383-B139-2B7EF6759C6FQ34226010-626E28C8-3906-4223-B608-C3E095803607Q34479082-8A4A944D-3BD4-489E-A083-04745D3E336FQ35025993-630F0A0E-69F1-4BFB-B950-6B27A55F71E9Q35163220-149BC254-C28B-44E3-9C65-7402620CADC2Q35224833-2C252F66-0D7A-40C1-B03F-BC6C5ECD317CQ35232775-ED99B6E3-8F1F-425D-93ED-542738E8341BQ35533531-36D4DBC0-F574-4A1C-B71C-E24F74F9144BQ35703714-0E6FCDA1-FA1E-44F1-A043-B61C72145A29Q36283958-D20F5E55-D900-4C73-B6DC-C47F3211C6A6Q36355093-C3E9B3CE-7F0E-4A04-9E40-08BCEED83D5BQ36360736-F99DE757-4BE5-4230-8395-8143A2CF1C2EQ36604739-A820DBC6-F281-464D-A622-E133C215C4F4Q36907048-AEB53F7A-8DBF-415E-A188-BD487E76F01FQ37122302-BC98D628-3278-49DC-9724-237DCFEDD80EQ37271019-16ED61AE-DFD9-4D10-B2C4-EDC4C365CCF1Q37391571-AF74C789-083F-46D5-B634-229A9ED71ED2Q37593800-E04964D1-6993-4378-B94B-3B1E7B76822AQ37809085-DAF300A4-AD5E-4203-A226-BD33A017F486Q37810079-5F7CCCC4-F16D-46AA-B8A9-6981A4C66ADBQ37863688-6ED2B0DC-1D6D-4A93-B0E1-629406523C7AQ37932546-B19BABF5-6E94-4029-9FD2-220CD7DFF810Q37942817-8D40593D-EE8C-41CC-8D02-8AB106F20BA6Q38046051-0A414226-3D63-4AE1-A8FC-A4CA73BA50BEQ38113568-EF139B4B-74FA-43F6-86F2-EF02D510367EQ38132821-0A9086AE-4CA5-4307-A4BA-E9AA1FF85258Q38198754-8FD4F970-212B-44CD-844E-8BBD1EBEA7D4Q38209433-ED52E6A2-EAB5-45ED-9217-44E2F34BE7BBQ38248359-41E4EC31-C444-43A1-9A3A-BAD87BEDADAFQ38528166-C6293F99-A280-4A4F-B594-1EA5E9F5E20AQ38635909-1B475B31-7C8C-445D-92FF-A01DAA5508F4Q38782072-AD579B0B-DAF1-4CF5-93A5-E7190776CDC3Q38949798-E9306809-6E69-4B25-9326-C5A4C84D4F63Q41928592-882A602E-BAB9-43A5-B4F9-1BABC2C1E79CQ42357660-F9C244A3-36E9-427E-8C19-34913F5602F0
P2860
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma
@ast
Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma
@en
Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma
@nl
type
label
Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma
@ast
Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma
@en
Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma
@nl
prefLabel
Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma
@ast
Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma
@en
Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma
@nl
P2093
P50
P3181
P356
P1433
P1476
Intensive chemotherapy (high-d ...... ith peripheral T-cell lymphoma
@en
P2093
A López-Guillermo
E Montserrat
Grup per l'Estudi dels Limfomes de Catalunya I Balears (GELCAB)
I Espinosa
S Mercadal
P304
P3181
P356
10.1093/ANNONC/MDN022
P407
P50
P577
2008-02-25T00:00:00Z